Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review

BACKGROUND: Since the implementation of the Regulation on Patient Integration (2003), the Act on the Reorganization of the Pharmaceutical Market (2011), and the Patient Rights Law (2013), the inclusion of patient perspectives has been further anchored in the German early benefit assessment process....

Descripción completa

Detalles Bibliográficos
Autores principales: Babac, Ana, Damm, Kathrin, Graf von der Schulenburg, J.-Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909645/
https://www.ncbi.nlm.nih.gov/pubmed/31832812
http://dx.doi.org/10.1186/s13561-019-0251-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909645/
https://www.ncbi.nlm.nih.gov/pubmed/31832812
http://dx.doi.org/10.1186/s13561-019-0251-9

Ejemplares similares